LTK-14A
LTK-14A, a derivative of Garcinol , is a selective histone butyrylation inhibitor. LTK-14A does not affect acetylation. LTK-14A significantly inhibits the butyrylation of H4K5 and downregulated the expression of proadipogenic genes, thus culminating in abolished adipogenesis. LTK-14A can be used for the study of obesity[1].
Product Specifications
CAS Number
71118-00-8
UNSPSC
12352005
Target
HDAC
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Field of Research
Metabolic Disease
Smiles
O=C([C@]1(C(C)2C)C/C=C(C)\C)[C@@](C[C@H]2C/C=C(C)/C)(C[C@@H]3C/C=C(C)\C)C(OC(C)3C)=C(C1=O)C(C(C=C4)=CC(OC)=C4OC)=O
Molecular Formula
C40H54O6
Molecular Weight
630.85
References & Citations
[1]Bhattacharya A, et al. Butyrylation Meets Adipogenesis-Probed by a p300-Catalyzed Acylation-Specific Small Molecule Inhibitor: Implication in Anti-obesity Therapy. J Med Chem. 2022 Sep 22;65 (18) :12273-12291.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
137670-ML490 100 µL
CD21 (Complement Receptor Type 2, Cr2, Complement C3d Receptor, Epstein-Barr Virus Receptor, EBV Receptor, CR2, C3DR, SLEB9) (MaxLight 490) discontinued
Sign In for Pricing
View Details 
MBS9450911-01 0.1 mL (Biotin)
Tumor Necrosis Factor Receptor Superfamily Member 11A Polyclonal Conjugated Antibody
Sign In for Pricing
View Details 
MBS9450911-02 0.1 mL (AF350)
Tumor Necrosis Factor Receptor Superfamily Member 11A Polyclonal Conjugated Antibody
Sign In for Pricing
View Details MBS9450911-03 0.1 mL (AF405)
Tumor Necrosis Factor Receptor Superfamily Member 11A Polyclonal Conjugated Antibody
Sign In for Pricing
View Details